Glenmark's marketing portfolio as of December 2024 had 201 generic products authorised for distribution in the US. The ...

Indian pharma major Glenmark Pharmaceuticals Limited and Canadian pharmaceutical company SaNOtize Research & Development Corp, on Wednesday announced launch of nasal spray to treat adult Covid-19 ...

Ryaltris, which was developed by Glenmark, is a novel, fixed-dose combination nasal spray of an anti-histamine (olopatadine hydrochloride) and a steroid (mometasone furoate). Each unit of the ...

The first recall affects 45,504 bottles of Ryaltris (olopatadine hydrochloride and mometasone furoate) Nasal Spray. Glenmark Pharmaceuticals Inc., based in New Jersey and a subsidiary of the ...

approval for nasal spray fixed dose prescription drug for seasonal allergic rhinitis Ryaltris. According to Glenmark, the drug is for rhinitis in adults and paediatric patients 12 years of age and ...